In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes

In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes

Context Cepharanthine (CEP) extracted from the roots of Stephania cepharantha Hayata (Menispermaceae), has a range of therapeutic potential in clinical conditions. Whether it affects the activity of human liver cytochrome P450 (CYP) enzymes remains unclear. Materials and methods The effects of CEP (...

Full description

Bibliographic Details
Main Authors:	Xunge Zhang, Ping Feng, Xinfu Gao, Bin Wang, Chunxia Gou, Ruimin Bian
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2020-01-01
Series:	Pharmaceutical Biology
Subjects:	cyp3a4 cyp2e1 cyp2c9 drug–drug interaction
Online Access:	http://dx.doi.org/10.1080/13880209.2020.1741650

Similar Items

In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes
by: Ning Zhang, et al.
Published: (2019-01-01)

In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes
by: Gang Dong, et al.
Published: (2018-01-01)

In vitro inhibitory effects of ganoderic acid A on human liver cytochrome P450 enzymes
by: Shangchen Xu, et al.
Published: (2020-01-01)

In vitro inhibitory effect of lysionotin on the activity of cytochrome P450 enzymes
by: Yang Li, et al.
Published: (2020-01-01)

In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes
by: Jinlan Wei, et al.
Published: (2018-01-01)

In vitro study on the effect of peucedanol on the activity of cytochrome P450 enzymes
by: Cun Zhang, et al.
Published: (2021-01-01)

FREQUENCIES OF POLYMORPHISMS IN THE CYTOCHROME’S P450 GENES OF WARFARIN TRANSFORMATION IN A EUROPEAN POPULATION OF EASTERN SIBERIA
by: T. A. Bairova, et al.
Published: (2018-09-01)

Effect of Bakumondo-to on cytochrome P450 activities in rat liver microsomes
by: Masako Yasuhara, et al.
Published: (2016-04-01)

Roles of Human Liver Cytochrome P450 Enzymes in Tenatoprazole Metabolism
by: Thien-Kim Le, et al.
Published: (2022-12-01)

Frequencies of Combined Dysfunction of Cytochromes P450 2C9, 2C19, and 2D6 in an Italian Cohort: Suggestions for a More Appropriate Medication Prescribing Process
by: Giovanna Gentile, et al.
Published: (2023-08-01)

Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification
by: Kata W. Pedersen, et al.
Published: (2021-10-01)

Effects of short-chain per- and polyfluoroalkyl substances (PFAS) on human cytochrome P450 (CYP450) enzymes and human hepatocytes: An in vitro study
by: Megan E. Solan, et al.
Published: (2023-01-01)

Variability in Loss of Multiple Enzyme Activities Due to the Human Genetic Variation P284T Located in the Flexible Hinge Region of NADPH Cytochrome P450 Oxidoreductase
by: Shaheena Parween, et al.
Published: (2019-10-01)

Exploring the Chemical Space of Cytochrome P450 Inhibitors using Integrated Physicochemical Parameters, Drug Efficiency Metrics and Decision Tree Models
by: Yusra Sajid Kiani, et al.
Published: (2019-05-01)

Modulatory effects of Benjakul extract on rat hepatic cytochrome P450 enzymes
by: Suchittra Samuhasaneeto, et al.
Published: (2021-11-01)

Mutual Influence of Human Cytochrome P450 Enzymes and UDP-Glucuronosyltransferases on Their Respective Activities in Recombinant Fission Yeast
by: Sangeeta Shrestha Sharma, et al.
Published: (2023-01-01)

Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs
by: Tyler C. Beck, et al.
Published: (2021-05-01)

Sensing the Generation of Intracellular Free Electrons Using the Inactive Catalytic Subunit of Cytochrome P450s as a Sink
by: Damilare D. Akintade, et al.
Published: (2020-07-01)

Inhibitory Mechanisms of Lekethromycin in Dog Liver Cytochrome P450 Enzymes Based on UPLC-MS/MS Cocktail Method
by: Pan Sun, et al.
Published: (2023-10-01)

The responses of the growth, cytochrome P450 isoenzymes activities and the metabolomics in earthworms to sublethal doses of dichlorvos in soil
by: Xiaoxia Yang, et al.
Published: (2021-01-01)

Association between Cytochrome P450 2 C9 and Vitamin K Epoxide Reductase Complex Subunit 1 Polymorphisms with Warfarin dose among Iranian Patients
by: Reyhaneh Kameli, et al.
Published: (2016-11-01)

Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes
by: Mingwei Wang, et al.
Published: (2020-01-01)

Interactions of Mycotoxin Alternariol with Cytochrome P450 Enzymes and OATP Transporters
by: Eszter Fliszár-Nyúl, et al.
Published: (2022-12-01)

Effects of ginkgo leaf tablet on the pharmacokinetics of rosiglitazone in rats and its potential mechanism
by: Xueting Xing, et al.
Published: (2022-12-01)

DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ASSAY OF SUBSTRATES-MARKERS OF MAIN CYTOCHROME P450 ISOFORMS AND THEIR METABOLITES USING HPLC-MS/MS
by: E. A. Egorenkov, et al.
Published: (2019-01-01)

Inhibitory effects of herbal medicines with claimed anticancer indications on cytochrome P450—An evaluation of drug-herb interactions risk
by: Misheck Mudyiwa, et al.
Published: (2023-09-01)

Genetic risk factors of cytolysis syndrome in the treatment of recrudescence of chronic cardiovascular diseases
by: N. V. Kokh, et al.
Published: (2018-11-01)

Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative
by: Muh. Akbar Bahar, et al.
Published: (2020-05-01)

Inhibitory effect of Selaginella doederleinii hieron on human cytochrome P450
by: Fei Lin, et al.
Published: (2023-02-01)

Inhibitory mechanism of vortioxetine on CYP450 enzymes in human and rat liver microsomes
by: Yunyun Zhan, et al.
Published: (2023-09-01)

Enzymatic activity in turkey, duck, quail and chicken liver microsomes against four human cytochrome P450 prototype substrates and aflatoxin B1
by: Hansen W. Murcia, et al.
Published: (2011-10-01)

Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes
by: Rohitash Jamwal, et al.
Published: (2020-08-01)

Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus
by: Sabina Semiz, et al.
Published: (2010-11-01)

CYP2C8 and CYP2C9 mRNA expression profile in the human fetus
by: Maria eJohansson, et al.
Published: (2014-03-01)

Inhibitory Interactions of Aspalathus linearis (Rooibos) Extracts and Compounds, Aspalathin and Z-2-(β-d-Glucopyranosyloxy)-3-phenylpropenoic Acid, on Cytochromes Metabolizing Hypoglycemic and Hypolipidemic Drugs
by: Oelfah Patel, et al.
Published: (2016-11-01)

Evaluation of lentinan effects on cytochrome P450 activity in rats by a cocktail method
by: Yiping Lin, et al.
Published: (2019-03-01)

Genetic abnormality of cytochrome-P2C9*3 allele predisposes to epilepsy and phenytoin-induced adverse drug reactions: genotyping findings of cytochrome-alleles in the North Indian population
by: Vivek Kumar Garg, et al.
Published: (2022-10-01)

Effects of Cytochrome P450 and Transporter Polymorphisms on the Bioavailability and Safety of Dutasteride and Tamsulosin
by: Gonzalo Villapalos-García, et al.
Published: (2021-10-01)

The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo
by: Sychev DA, et al.
Published: (2018-05-01)

Genetic Polymorphisms of Cytochromes P450 in Finno-Permic Populations of Russia
by: Murat Dzhaubermezov, et al.
Published: (2022-12-01)